Abbvie Inc (NYSE:ABBV)
| 83.45 BATS BZX Real-Time Price As of 3:37pm ET |  -1.82 / -2.13%Today’s Change | 62.66 Today|||52-Week Range 91.99 | -5.75% Year-to-Date |
Latest ABBV News | Press Releases
| Better Buy: AbbVie vs. Johnson & Johnson 10:00am / MotleyFool.com - Paid Partner Content | 5 Key Things Investors Should Look Forward to With AbbVie in 2020 Jan 16 / MotleyFool.com - Paid Partner Content |
| 2 Dividend-Paying Biotech Stocks Worth Owning in 2020 Jan 23 / MotleyFool.com - Paid Partner Content | The Best Large-Cap ETFs to Buy in 2020 Jan 16 / MotleyFool.com - Paid Partner Content |
| 2 Biotechs Battling Immune Diseases Jan 19 / MotleyFool.com - Paid Partner Content | High Drug Prices Remains a Top Issue in Democratic Debates Jan 15 / MotleyFool.com - Paid Partner Content |
| Better Buy: Abbott Laboratories vs. AbbVie Jan 19 / MotleyFool.com - Paid Partner Content | AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis Jan 14 / MotleyFool.com - Paid Partner Content |
| Why AbbVie Stock Dipped in 2019 Jan 16 / MotleyFool.com - Paid Partner Content | Why AbbVie Could Be a Great Buy in 2020 Jan 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 85.27 |
| Today’s open | 86.92 |
| Day’s range | 82.83 - 85.47 |
| Volume | 10,074,845 |
| Average volume (3 months) | 7,600,652 |
| Market cap | $130.2B |
Data as of 3:37pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | +10.88% |
| Earnings growth (this year) | +12.92% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +16.08% |
| P/E ratio | 36.8 |
| Price/Sales | 4.35 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | -0.79 | -1.59% |
| AZNAstraZeneca | -0.94 | -1.86% |
| GSKGlaxoSmithKline | -0.52 | -1.09% |
| LLYEli Lilly and Co | -2.20 | -1.56% |
Data as of 3:37pm ET, 01/24/2020
Financials
| Next reporting date | February 7, 2020 |
| EPS forecast (this quarter) | $2.19 |
| Annual revenue (last year) | $32.8B |
| Annual profit (last year) | $5.7B |
| Net profit margin | 17.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
